Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Mar 6, 2013, we reiterated our long-term recommendation on PNC Financial Services Group Inc. ( PNC - Analyst Report ) at Neutral based on its diverse revenue mix, balance sheet strengthening efforts, strategic acquisitions and solid capital levels. However, a tepid economic recovery with continued low interest rate environment and increased regulatory headwinds are our concerns.
Why Neutral?
PNC Financial’s fourth quarter 2012 adjusted earnings per share of $1.71 significantly exceeded the Zacks Consensus Estimate of $1.37. However, results were below the earnings per share of $1.74 recorded in the prior quarter.
Better-than-expected results reflect improved net interest income. Moreover, lower nonperforming assets, reduced charge-offs along with healthy capital levels were the positives.
However, PNC Financial’s non-interest expense was $2.8 billion, up 7% from the last quarter. The hike reflected increase in personnel costs along with increased expenses for residential mortgage foreclosure-related matters. Further, PNC Financial’s provision for credit losses was $318 million, up 39% sequentially. This was mainly attributable to a larger loan portfolio and reduced reserve release in commercial lending.
Over the last 7 days, the Zacks Consensus Estimate for 2013 and 2014 remained stable at $6.58 and $6.86 per share, respectively. With the Zacks Consensus Estimates remaining constant, the company retains a Zacks Rank #3 (Hold).
Other Major Banks to Consider
Among peers of PNC Financial, BankUnited Inc. ( BKU - Analyst Report ) holds a Zacks Rank #1 (Strong Buy), while Fifth Third Bancorp ( FITB - Analyst Report ) and State Street Corporation ( STT - Analyst Report ) retain a Zacks Rank #2 (Buy).
Read the full Analyst Report on PNC
Read the full Analyst Report on FITB
Read the full Analyst Report on STT
Read the full Analyst Report on BKU